Barnes Alane P 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 16, 2025
Insider Transaction Report
Form 4
Barnes Alane P
VP, General Counsel & Corp Sec
Transactions
- Tax Payment
Common Stock
2025-12-12$7.57/sh−8,540$64,648→ 336,936 total - Sale
Common Stock
2025-12-15$7.65/sh−21,210$162,257→ 315,726 total
Footnotes (2)
- [F1]Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person.
- [F2]This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.